Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy
Pharmaceuticals · 15.05.2024 · 17 (5) · 636
DOI: 10.3390/ph17050636 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.05.2024. Verfasst von Ziqing He und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-T…. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 270 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Scientific and Technological Innovation Major Base of Guangxi.
Abstract (Originalsprache)
Astragalus polysaccharide (APS) derived from A. membranaceus plays a crucial role in traditional Chinese medicine. These polysaccharides have shown antitumor effects and are considered safe. Thus, they have become increasingly important in cancer immunotherapy. APS can limit the spread of cancer by influencing immune cells, promoting cell death, triggering cancer cell autophagy, and impacting the tumor microenvironment. When used in combination with other therapies, APS can enhance treatment outcomes and reduce toxicity and side effects. APS combined with immune checkpoint inhibitors, relay cellular immunotherapy, and cancer vaccines have broadened the application of cancer immunotherapy and enhanced treatment effectiveness. By summarizing the research on APS in cancer immunotherapy over the past two decades, this review elaborates on the anticancer mechanism of APS and its use in cancer immunotherapy and clinical trials. Considering the multiple roles of APS, this review emphasizes the importance of using APS as an adjunct to cancer immunotherapy and compares other polysaccharides with APS. This discussion provides insights into the specific mechanism of action of APS, reveals the molecular targets of APS for developing effective clinical strategies, and highlights the wide application of APS in clinical cancer therapy in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting T…
- School of Pharmacy, Guangxi Medical University, Nanning 530021, China.
ORCID-Profile: Ziqing He
Förderung
- the Scientific and Technological Innovation Major Base of Guangxi
Zitieren
APA
He, Z., Liu, X., Qin, S., Yang, Q., Na, J., Xue, Z., & Zhong, L. (2024). Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy. Pharmaceuticals, 17(5), 636. https://doi.org/10.3390/ph17050636
Vancouver
He Z, Liu X, Qin S, Yang Q, Na J, Xue Z, et al. Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy. Pharmaceuticals. 2024;17(5):636. doi:10.3390/ph17050636
BibTeX
@article{He2024,
author = {He, Ziqing and Liu, Xiyu and Qin, Simin and Yang, Qun and Na, Jintong and Xue, Zhigang and Zhong, Liping},
title = {Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {5},
pages = {636},
doi = {10.3390/ph17050636}
}
EUVIMED